Attivare Therapeutics: Funding, Investors & Team (Oct 2026)
Attivare Therapeutics is a biotechnology company focused on discovering and developing small-molecule therapies that modulate immune and inflammatory pathways. The company’s research centers on activating specific biological mechanisms involved in innate immunity to address diseases where immune response plays a central role. Its pipeline includes orally administered drug candidates designed to target well-defined molecular pathways, with an emphasis on translating foundational immunology research into clinical applications. Attivare Therapeutics conducts preclinical and clinical development activities, including target validation, medicinal chemistry, pharmacology, and safety evaluation. The company also engages in translational research to identify biomarkers that support patient selection and therapeutic monitoring. Through collaborations with academic researchers and industry partners, Attivare Therapeutics advances programs aimed at treating inflammatory, autoimmune, and immune-mediated conditions.
Attivare Therapeutics has raised $6.6M across 1 funding round on record, the most recent an undisclosed round of $6.6M announced in Dec 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Attivare Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Attivare Therapeutics Funding Rounds
Attivare Therapeutics Founders and Leadership Team
Contact details for the Attivare Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Attivare Therapeutics Funding Compared to Other Biotechnology Startups
Attivare Therapeutics' latest round of $6.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Attivare Therapeutics in Biotechnology and Natick
Companies Similar to Attivare Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Attivare Therapeutics Funding FAQs
What does Attivare Therapeutics do?
Attivare Therapeutics is a biotechnology company focused on discovering and developing small-molecule therapies that modulate immune and inflammatory pathways. The company’s research centers on activating specific biological mechanisms involved in innate immunity to address diseases where immune response plays a central role. Its pipeline includes orally administered drug candidates designed to target well-defined molecular pathways, with an emphasis on translating foundational immunology research into clinical applications. Attivare Therapeutics conducts preclinical and clinical development activities, including target validation, medicinal chemistry, pharmacology, and safety evaluation. The company also engages in translational research to identify biomarkers that support patient selection and therapeutic monitoring. Through collaborations with academic researchers and industry partners, Attivare Therapeutics advances programs aimed at treating inflammatory, autoimmune, and immune-mediated conditions.
How much funding has Attivare Therapeutics raised?
Attivare Therapeutics has raised $6.6M across 1 round on record. The most recent is an undisclosed round of $6.6M announced in Dec 2025.
When did Attivare Therapeutics last raise funding?
Attivare Therapeutics' most recent funding round on record is an undisclosed round of $6.6M, announced in Dec 2025.
Who founded Attivare Therapeutics?
FundedIQ lists Fernanda Langellotto (Founder) at Attivare Therapeutics.
Where is Attivare Therapeutics headquartered?
Attivare Therapeutics is based in Natick, Massachusetts, United States.
How many employees does Attivare Therapeutics have?
Attivare Therapeutics is in the 1-10 employee band.
How does Attivare Therapeutics' funding compare to other Biotechnology startups?
Attivare Therapeutics' latest round of $6.6M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Attivare Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Attivare Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.